Document Detail


Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cells.
MedLine Citation:
PMID:  22549737     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The tyrosine kinase c-Abl localizes to the mitochondria under cell stress conditions and promotes apoptosis. However, c-Abl has not been directly targeted to the mitochondria. Fusing c-Abl to a mitochondrial translocation signal (MTS) that is activated by reactive oxygen species (ROS) will selectively target the mitochondria of cancer cells exhibiting an elevated ROS phenotype. Mitochondrially targeted c-Abl will thereby induce malignant cell death.
METHODS: Confocal microscopy was used to determine mitochondrial colocalization of ectopically expressed c-Abl-EGFP/cMTS fusion across three cell lines (K562, Cos-7, and 1471.1) with varying levels of basal (and pharmacologically modulated) ROS. ROS were quantified by indicator dye assay. The functional consequences of mitochondrial c-Abl were assessed by DNA accessibility to 7-AAD using flow cytometry.
RESULTS: The cMTS and cMTS/c-Abl fusions colocalized to the mitochondria in leukemic (K562) and breast (1471.1) cancer phenotypes (but not Cos-7 fibroblasts) in a ROS and PKC dependent manner.
CONCLUSIONS: We confirm and extend oxidative stress activated translocation of the cMTS by demonstrating that the cMTS and Abl/cMTS fusion selectively target the mitochondria of K562 leukemia and mammary adenocarcinoma 1471.1 cells. c-Abl induced K562 leukemia cell death when targeted to the matrix but not the outer membrane of the mitochondria.
Authors:
Jonathan E Constance; Samuel D Despres; Akemi Nishida; Carol S Lim
Related Documents :
22437817 - Engineering quasi-vivo® in vitro organ models.
12713137 - The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian car...
16330937 - Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papilla...
15073597 - A distinct expression pattern and point mutation of c-kit in papillary renal cell carci...
24909567 - Distinct effect of methotrexate and etanercept on the b cell compartment in patients wi...
21665377 - Low concentrations of alendronate increase the local invasive potential of osteoblastic...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-05-02
Journal Detail:
Title:  Pharmaceutical research     Volume:  29     ISSN:  1573-904X     ISO Abbreviation:  Pharm. Res.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-18     Completed Date:  2012-11-23     Revised Date:  2013-08-14    
Medline Journal Info:
Nlm Unique ID:  8406521     Medline TA:  Pharm Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2317-28     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah 84108, USA. Jonathan.Constance@utah.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
COS Cells
Cell Death
Cell Line, Tumor
Cercopithecus aethiops
Female
Gene Expression
Humans
Leukemia / genetics,  metabolism*,  pathology
Mammary Neoplasms, Animal / genetics,  metabolism*,  pathology
Mice
Mitochondria / genetics,  metabolism*,  pathology
Molecular Sequence Data
Oxidative Stress
Protein Transport
Proto-Oncogene Proteins c-abl / analysis,  genetics,  metabolism*
Reactive Oxygen Species / metabolism*
Recombinant Fusion Proteins / analysis,  genetics,  metabolism
Grant Support
ID/Acronym/Agency:
P30CA042014/CA/NCI NIH HHS; R01 CA129528/CA/NCI NIH HHS; R01-CA129528/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Reactive Oxygen Species; 0/Recombinant Fusion Proteins; EC 2.7.10.2/Proto-Oncogene Proteins c-abl
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hydroxylation of R(+)- and S(-)-Omeprazole after Racemic Dosing are Different among the CYP2C19 Geno...
Next Document:  Preparation of Rotigotine-Loaded Microspheres and Their Combination Use with L-DOPA to Modify Dyskin...